Literature DB >> 2910420

Long-term vocational adjustment of cancer patients diagnosed during adolescence.

C K Tebbi1, C Bromberg, M Piedmonte.   

Abstract

Long-term vocational achievements of 40 survivors of cancer diagnosed during adolescence were examined and compared with 40 healthy sex-matched and age-matched controls. Patients' ages at diagnosis ranged from 13 to 19 years (mean, 16.15). Study subjects had survived cancer for over 5 years and were on no cancer therapy. Assessment measures included the Rand General Well-Being Scale, the Rand Functional Limitations and Physical Abilities Batteries, and a semistructured interview. The relation of physical disability and limitations caused by cancer to patients' achievements also was evaluated. Although cancer patients, on the average, were more concerned about their health and reported lower general spirits than controls, no differences were found between control and study groups with regard to overall general well-being. More cancer patients than controls reported that their health limited their ability to engage in vigorous activities. A greater functional deficit was found among unemployed than employed cancer patients. Employers and co-workers often were aware of the patient's diagnosis (85% and 67%, respectively). Cancer patients reported disease-related discrimination in hiring (7.4%), induction into the military (66.7%), and obtaining health, life, and disability insurance (31.5%). There was no significant relationship between health status and employment. Nevertheless, cancer patients had a higher average income than controls. Sixty-four percent of patients believed that changes in certain physical features of the workplace were necessary to facilitate readjustment to the job. Despite the disabilities experienced by cancer patients and generally negative public attitudes, long-term survivors have a good outlook on life and are competitive members of the workplace and society.

Entities:  

Mesh:

Year:  1989        PMID: 2910420     DOI: 10.1002/1097-0142(19890101)63:1<213::aid-cncr2820630134>3.0.co;2-t

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

1.  The effects of response bias on self-reported quality of life among childhood cancer survivors.

Authors:  Tara E O'Leary; Lisa Diller; Christopher J Recklitis
Journal:  Qual Life Res       Date:  2007-07-11       Impact factor: 4.147

Review 2.  CNS prophylaxis of childhood leukemia: what are the long-term neurological, neuropsychological, and behavioral effects?

Authors:  J A Stehbens; T A Kaleita; R B Noll; W E MacLean; R T O'Brien; M J Waskerwitz; G D Hammond
Journal:  Neuropsychol Rev       Date:  1991-06       Impact factor: 7.444

3.  [Changes in occupational status following cancer. An empirical study on occupational rehabilitation].

Authors:  J Weis; U Koch; M Geldsetzer
Journal:  Soz Praventivmed       Date:  1992

4.  Employment in a cohort of cancer patients in Spain. A predictive model of working outcomes.

Authors:  Raquel Molina; Jaime Feliu; Alejandro Villalba; Belén San José; Ana María Jiménez; Enrique Espinosa; Melchor Alvarez-Mon; Manuel González-Barón
Journal:  Clin Transl Oncol       Date:  2008-12       Impact factor: 3.405

Review 5.  Employment among Childhood Cancer Survivors: A Systematic Review and Meta-Analysis.

Authors:  Alessandro Godono; Francesco Felicetti; Alessio Conti; Marco Clari; Margherita Dionisi-Vici; Filippo Gatti; Catalina Ciocan; Tommaso Pinto; Emanuela Arvat; Enrico Brignardello; Franca Fagioli; Enrico Pira
Journal:  Cancers (Basel)       Date:  2022-09-22       Impact factor: 6.575

6.  Reliability and validity of functional health status and health-related quality of life questionnaires in children with recurrent acute otitis media.

Authors:  Carole N M Brouwer; Anne G M Schilder; Henk F van Stel; Maroeska M Rovers; Reinier H Veenhoven; Diederick E Grobbee; Elisabeth A M Sanders; A Rianne Maillé
Journal:  Qual Life Res       Date:  2007-08-01       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.